Showing results (1251-1260 of 1,676) with videos related to
Sort By:
Pageof 168
Arthritis Care & Research|April 23, 2019
Patient and Rheumatologist Perspectives Regarding Challenges to Achieving Optimal Disease Control in Rheumatoid ArthritisJustin K Owensby, Lang Chen, Ronan O'Beirne, et al.European Journal of Medicinal Chemistry|April 2, 2015
3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activityRobert L Hudkins, Nadine C Becknell, Jacquelyn A Lyons, et al.Addiction Neuroscience|February 17, 2023
Sex-related differences in endogenous pituitary adenylate cyclase-activating polypeptide (PACAP) in the thalamic paraventricular nucleus: Implications for addiction neuroscienceGenevieve R Curtis, Andrew T Gargiulo, Brody A Carpenter, et al.Arthritis Care & Research|May 8, 2024
Real-World Effectiveness of Pegloticase Associated With Use of Concomitant Immunomodulatory TherapyEmily E Holladay, Amy S Mudano, Fenglong Xie, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 3, 2026
Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general-population cohort analysis with extended quantile g-computationNaizhuo Zhao, Sasha Bernatsky, Sharon Dowell, et al.Critical Care Medicine|February 22, 2011
Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndromeHollis R O'Neal, Tatsuki Koyama, Elizabeth A S Koehler, et al.Annals of the Rheumatic Diseases|November 27, 2010
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritisJeffrey D Greenberg, Joel M Kremer, Jeffrey R Curtis, et al.Seminars in Arthritis and Rheumatism|September 10, 2013
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugsDaniel H Solomon, Joel M Kremer, Mark Fisher, et al.Chest|February 25, 2016
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/ThrombosisAnand Padmanabhan, Curtis G Jones, Brian R Curtis, et al.The Journal of Rheumatology|November 16, 2020
Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 PandemicMichael D George, Shilpa Venkatachalam, Shubhasree Banerjee, et al.Pageof 168